Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Biotalys NV ( (DE:86C) ) has shared an update.
Biotalys NV has disclosed information about its outstanding share capital and voting rights in compliance with the Belgian Act on the disclosure of major shareholdings. The company’s share capital stands at EUR 5,540,603.84, with 37,470,062 ordinary shares carrying voting rights. The company also reported on various ESOP Warrants and share units, and highlighted the requirements for notifying changes in shareholding thresholds. This announcement provides transparency on the company’s capital structure, which is crucial for stakeholders monitoring ownership and investment impact.
More about Biotalys NV
Biotalys is an Agricultural Technology (AgTech) company focused on developing protein-based biocontrol solutions for crop protection. Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), the company aims to offer sustainable alternatives to chemical pesticides. Biotalys utilizes its AGROBODY™ technology platform to develop a diverse pipeline of safe and effective product candidates targeting key crop pests and diseases.
YTD Price Performance: -1.54%
Average Trading Volume: 794
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €124.4M
See more insights into 86C stock on TipRanks’ Stock Analysis page.
